APA (7th ed.) Citation

J, E., A, N., D, L., M, B., S, V., K, B., . . . A, S. (2024). Next generation risk assessment: An ab initio case study to assess the systemic safety of the cosmetic ingredient, benzyl salicylate, after dermal exposure. Frontiers in pharmacology, 15, 1345992. https://doi.org/10.3389/fphar.2024.1345992

Chicago Style (17th ed.) Citation

J, Ebmeyer, et al. "Next Generation Risk Assessment: An Ab Initio Case Study to Assess the Systemic Safety of the Cosmetic Ingredient, Benzyl Salicylate, After Dermal Exposure." Frontiers in Pharmacology 15 (2024): 1345992. https://doi.org/10.3389/fphar.2024.1345992.

MLA (9th ed.) Citation

J, Ebmeyer, et al. "Next Generation Risk Assessment: An Ab Initio Case Study to Assess the Systemic Safety of the Cosmetic Ingredient, Benzyl Salicylate, After Dermal Exposure." Frontiers in Pharmacology, vol. 15, 2024, p. 1345992, https://doi.org/10.3389/fphar.2024.1345992.